N

Natco Pharma Ltd

PharmaceuticalsSmallcap

About the company

Natco Pharma Limited is a research and development (R&D)-focused pharmaceutical company. The Company is engaged in developing, manufacturing and marketing finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs).

Performance

Stock
Loading Stock value

Analyst Ratings and Key Metrics

Based on 11 analysts offering recommendations for Natco Pharma Ltd

46%

Buy

27%

Hold

27%

Sell

Key MetricsThis StockCategory (Avg)
PE Ratio8.8134.78
PB Ratio2.185.49
Dividend Yield0.65%0.61%

Understand what these metrics mean. 

Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions